(Q33686303)

28 July 2017

1 reference

title

The treatment of Legionnaires' disease (English)

1 reference

28 July 2017

main subject

legionnaires' disease

1 reference

Dedicoat M

1

1 reference

28 July 2017

Venkatesan P

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Journal of Antimicrobial Chemotherapy

28 July 2017

published in

1 reference

28 July 2017

volume

43

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

747-752

1 reference

Legionnaires' disease: description of an epidemic of pneumonia

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Antimicrobial chemotherapy for legionnaires' disease: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

In vitro activity of azithromycin against clinical isolates of Legionella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Comparison of the activity of three antibiotic regimens in severe Legionnaires' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Comparative efficacy of five antibiotics on experimental airborne legionellosis in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

The activity of grepafloxacin against respiratory pathogens in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F43.6.747

21 January 2018

Identifiers

DOI

10.1093/JAC/43.6.747

1 reference

28 July 2017

1 reference